XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities:    
Net loss $ (121,994) $ (164,272)
Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]    
Depreciation 92,765 90,655
Equity Securities, FV-NI, Gain (Loss) 6,817 (1,772)
Deferred tax expense (benefit) (512) 1,827
Stock-based compensation 162,024 165,682
Gain on Settlement of Convertible Notes 0 10,254
Amortization of acquired intangible assets 72,461 71,057
Impairment of long-lived and indefinite-lived assets 6,794 31,296
Gain (Loss) On Contingent Consideration From Disposition Of Asset 0 (6,632)
Remeasurement of contingent consideration liabilities 21,901 (2,326)
Non-cash lease expense 20,248 20,645
Other Noncash Income (Expense) 8,867 (1,437)
Changes in assets and liabilities:    
Accounts receivable, net (56,233) (61,410)
Inventory, net (2,356) (9,516)
Increase (Decrease) in Operating Lease Liability (21,117) (19,345)
Accounts payable and accrued liabilities 165,183 38,258
Other assets (12,194) (6,358)
Other liabilities (13,659) 11,115
Net cash provided by operating activities 339,749 163,473
Cash flows from investing activities:    
Purchases of marketable securities (140,269) (405,385)
Maturities and sales of marketable securities 370,482 150,916
Purchases of property, plant and equipment (103,413) (99,673)
Payments to Acquire Intangible Assets 0 (45,000)
Payments to Acquire Other Investments (51,064) (916)
Proceeds From Contingent Consideration Receivable 27,971 0
Other investing activities 297 (225)
Net cash provided by (used in) investing activities 104,004 (400,283)
Cash flows from financing activities:    
Repayments of Convertible Debt (249,172) 0
Payment, Tax Withholding, Share-Based Payment Arrangement 80 767
Proceeds from Stock Plans 16,033 19,402
Repayments of Accounts Receivable Securitization 0 (50,000)
Proceeds from Convertible Debt 0 266,750
Payment for Contingent Consideration Liability, Financing Activities 19,000 0
Other financing activities (10,158) (15,544)
Net cash provided by (used in) financing activities (262,217) 221,375
Reconciliation of cash, cash equivalents and restricted cash:    
Cash and cash equivalents 789,037 588,830
Restricted cash — included in other long-term assets, net 0 5,837
Total cash, cash equivalents and restricted cash 789,037 594,667
Supplemental disclosure of cash flow information:    
Interest paid 24,281 21,109
Supplemental disclosure of non-cash investing and financing activities    
Issuance of common stock to fund the Company's 401(k) match 43,943 40,550
Property, plant and equipment acquired but not paid 10,773 11,904
Cash, cash equivalents and restricted cash, end of period 789,037 594,667
Cash, cash equivalents and restricted cash, beginning of period 606,636 609,675
Net increase (decrease) in cash, cash equivalents and restricted cash 182,401 (15,008)
Effects of exchange rate changes on cash and cash equivalents $ 865 $ 427